Healio

Wet AMD anti-VEGF injection persistence shows ‘considerable’ decline over 7 years

A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with wet ...
Seeking Alpha

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical (CLSD), Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Healio

Travel support may improve access to clinical care for patients with AMD

Please provide your email address to receive an email when new articles are posted on . Driving distance was inversely associated with the average number of injections per year. Travel reimbursement ...
Everyday Health

The Consumer’s Guide to Anti-VEGF Treatments for Wet AMD

Anti–vascular endothelial growth factor (VEGF) medications have been a mainstay of treatment for wet age-related macular degeneration (wet AMD) for 20 years — and for good reason. The medication has ...
News Medical

Oraya therapy is effective in maintaining vision with reduced injections for wet AMD patients

Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age ...